Federal Register of Legislation - Australian Government

Skip to primary navigation Skip to primary content
Federal Register of Legislation Skip to Content
SearchOpen search

Primary content

Bookmark

this version | go to latest

National Health (Weighted average disclosed price - main disclosure cycle) Amendment Determination 2014 (No. 1) (PB 8 of 2014)

Authoritative Version
PB 8 of 2014 Determinations/Health as made
This determination amends the National Health (Weighted average disclosed price - main disclosure cycle) Determination 2013 (No. 2) (No. PB 82 of 2013) to revoke a WADP for all brands of pharmaceutical items containing the drug morphine for administration by injection.
Administered by: Health
Registered 11 Feb 2014
Tabling HistoryDate
Tabled HR13-Feb-2014
Tabled Senate13-Feb-2014
Date of repeal 13 Feb 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 8 of 2014

National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2014 (No. 1)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this amendment determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated  6  February 2014

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

 

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

 

1              Name of Determination

       (1)     This Determination is the National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2014 (No. 1).

       (2)     This Determination may also be cited as PB 8 of 2014.

2              Commencement

                This Determination commences on the day after it is registered.

3              Amendments to PB 82 of 2013

Schedule 1 amends the National Health (Weighted average disclosed price - main disclosure cycle) Determination 2013 (No.2) (PB 82 of 2013).


Schedule 1             Amendments

 

 

1]       Schedule 1, After

 

1235

Mometasone

Ointment containing mometasone furoate
1 mg per g, 15 g

Application

Zatamil

4.52

 

omit:

1236

Morphine

Injection containing morphine sulfate 10 mg in 1 mL

Injection

Hospira Pty Limited

4.27

1237

Morphine

Injection containing morphine sulfate 15 mg in 1 mL

Injection

Hospira Pty Limited

4.58

1238

Morphine

Injection containing morphine sulfate 30 mg in 1 mL

Injection

Hospira Pty Limited

5.82

1239

Morphine

Injection containing morphine sulphate 10 mg in 1 mL (with preservative)

Injection

Morphine Sulphate Wockhardt

8.53

 1240

Morphine

Injection containing morphine tartrate 120 mg in 1.5 mL

Injection

Hospira Pty Limited

17.64

 

 

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.comlaw.gov.au/Home.